Episode 70: Matthias von Herrath, MD, Professor at the La Jolla Institute for Immunology and Vice President and Senior Medical Officer at Novo Nordisk
2021-04-01
In this episode, Dr. Matthias von Herrath joins us to discuss his work at the La Jolla Institute for Immunology and at pharmaceutical company Novo Nordisk. He discusses one of his recently published papers, "Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial".
Full paper link: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00019-X/fulltext
More Episodes
Heard on the Street: Tim Tree, PhD, Kings College London
2024-02-22
59
2024-02-22
59
Heard on the Street: Georgia Fousteri, PhD, Dompé
2024-02-21
59
2024-02-21
59
Heard on the Street: Rupangi Vasavada, PhD, City of Hope
2024-02-21
58
2024-02-21
58
Heard on the Street: Yuval Dror, PhD, Hebrew University
2024-02-21
57
2024-02-21
57
Get this podcast on your
phone, FREE
